News PortalZeus Hygia’s Metaberine® Clinical Study Published, Demonstrating Metabolic Health Benefits at just 200 mg Daily
The study reports improvements in glycemic control, GLP-1 response and lipid markers with bio-optimised berberine Hyderabad, August 14, 2026: Zeus Hygia Lifesciences, an innovator in nutraceutical solutions, today announced the publication of a clinical study evaluating Metaberine®, its bio-optimised berberine formulation developed using proprietary BioSOLVE® Technology . Published in the International Journal of Clinical Trials , the randomized, double-blind, placebo-controlled
Aug 14, 2026